Last reviewed · How we verify

Dispersion of 6% BEMT in petrolatum

dsm-firmenich Switzerland AG · Phase 2 active Small molecule

Dispersion of 6% BEMT in petrolatum is a Small molecule drug developed by dsm-firmenich Switzerland AG. It is currently in Phase 2 development. Also known as: PARSOL® SHIELD, SU-E-101413-82.

At a glance

Generic nameDispersion of 6% BEMT in petrolatum
Also known asPARSOL® SHIELD, SU-E-101413-82
Sponsordsm-firmenich Switzerland AG
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Dispersion of 6% BEMT in petrolatum

What is Dispersion of 6% BEMT in petrolatum?

Dispersion of 6% BEMT in petrolatum is a Small molecule drug developed by dsm-firmenich Switzerland AG.

Who makes Dispersion of 6% BEMT in petrolatum?

Dispersion of 6% BEMT in petrolatum is developed by dsm-firmenich Switzerland AG (see full dsm-firmenich Switzerland AG pipeline at /company/dsm-firmenich-switzerland-ag).

Is Dispersion of 6% BEMT in petrolatum also known as anything else?

Dispersion of 6% BEMT in petrolatum is also known as PARSOL® SHIELD, SU-E-101413-82.

What development phase is Dispersion of 6% BEMT in petrolatum in?

Dispersion of 6% BEMT in petrolatum is in Phase 2.

Related